Personalized medicine has become a buzzword among the medical community and for good reason — managing your risk of disease has become easier and more accessible with the advent of DNA testing. But you’re not going to be offered a full genetic workup at your family doctor’s office just yet, so many patients are turning to direct-to-consumer services to find out their risk of future diseases.
One of the more popular genetic medicine services, 23andMe, an American company with more than two million clients worldwide, offers customers a look inside their genome, reporting on approximately 70 health conditions and traits. The data is analyzed through spit, which customers mail to a lab. In approximately six to eight weeks, individuals receive online reports on their genetic health.
There are only four main disease risks that the company currently reports on, including late-onset Alzheimer’s disease, Parkinson’s disease, alpha-1 antitrypsin deficiency, a disorder that causes lung and liver disease,